Ti Badri

1.9k citations
5 papers · 323 indexed · 1 hit paper · h-index 3
Topics
Single-cell and spatial transcriptomics (2 papers)Cancer Cells and Metastasis (2 papers)Cancer Genomics and Diagnostics (1 paper)
Partner nations
United StatesSpainFrance

In The Last Decade

Ti Badri

5 papers receiving 322 citations

Hit Papers

T cell characteristics associated with toxicity to immune...2022202620232024202250100150

Peers

Ti Badri
Comparison fields: 5 of 53
  • Oncology 194
  • Immunology 176
  • Pulmonary and Respiratory Medicine 51
  • Molecular Biology 49
  • Epidemiology 39
Replace Kieran Adam with:
Kieran Adam United States
Stefan Schliep Germany
Mirjam Fässler Switzerland
Ian W. Folkert United States
Ayman Al‐Habeeb Canada
Ileana Passadore Italy
Rosa DaCosta United States
Jérôme Le Priol France
Laetitia Da Meda France
Takenori Uehara Japan
Ti Badri relative to Kieran Adam United States Kieran Adam's profile →
Citations per field
00.5×1.5×2.1×
Kieran Adam · 1×
Citations per year

Countries citing papers authored by Ti Badri

Since Specialization
Citations

This map shows the geographic impact of Ti Badri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ti Badri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ti Badri more than expected).

Fields of papers citing papers by Ti Badri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ti Badri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ti Badri. The network helps show where Ti Badri may publish in the future.

Co-authorship network of co-authors of Ti Badri

This figure shows the co-authorship network connecting the top 25 collaborators of Ti Badri. A scholar is included among the top collaborators of Ti Badri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ti Badri. Ti Badri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanomabreakdown →
180
2 1
3 1
4 40
5 101

About Ti Badri

Ti Badri is a scholar working on Immunology, Oncology and Genetics, having authored 5 papers that have together received 323 indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (2 papers), Cancer Cells and Metastasis (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (176 citations), Oncology (194 citations) and Genetics (25 citations). Ti Badri has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Matthew D. Vesely, David Y. Chen, Brandon E. Turner, Ruth Halaban, Aaron M. Newman, Bogdan Luca, Peter K. Harris, Noah Earland, Mario Sznol and Kavita M. Dhodapkar. Their work appears in journals such as Nature Medicine, Science Translational Medicine and Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026